Literature DB >> 7963733

Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection.

E Chungue1, L Poli, C Roche, P Gestas, P Glaziou, L J Markoff.   

Abstract

Although dengue fever (DF) is usually self-limited, some patients experience severe and prolonged illness characterized by capillary leakage, which may progress to hypovolemic shock (dengue hemorrhagic fever/dengue shock syndrome; DHF/DSS) with hemorrhage of unknown etiology. Development of antibodies potentially cross-reactive to plasminogen has been reported in a high percentage of Thai patients with DF and DHF/DSS. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage was evaluated in 88 Tahitian children with dengue virus type 3 infection who presented with (n = 59) or without (n = 29) hemorrhage. Plasminogen cross-reactive antibodies were found in acute and convalescent sera of 33 and 11 children, respectively (56% vs. 31%, P < .05), and closely paralleled antibodies to the cross-reactive site in dengue virus E protein. Antibodies were more frequent in children with secondary than primary infections (60% vs. 32%, P < .05). Plasminogen cross-reactive antibodies did not correlate with occurrence of DHF/DSS or thrombocytopenia. These results are consistent with the possibility that plasminogen cross-reactive antibodies play a role in the etiology of hemorrhage in dengue virus infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963733     DOI: 10.1093/infdis/170.5.1304

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Authors:  Lucile Warter; Ramapraba Appanna; Katja Fink
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Dengue fever as a rare cause of pulmonary embolism.

Authors:  Francesco Poletto; Lorenzo Cerruti; Luca Spiezia
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

4.  Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis.

Authors:  Yung-Chun Chuang; Yee-Shin Lin; Hsiao-Sheng Liu; Trai-Ming Yeh
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

5.  Fibrin formation and lysis studies in dengue virus infection.

Authors:  Rita Marchi; Chandrasekaran Nagaswami; John W Weisel
Journal:  Blood Coagul Fibrinolysis       Date:  2009-10       Impact factor: 1.276

Review 6.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Dengue: A Clinicohaematological Profile.

Authors:  M Banerjee; T Chatterjee; G S Choudhary; V Srinivas; V K Kataria
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 8.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

Review 9.  Current progress in dengue vaccines.

Authors:  Shu-Wen Wan; Chiou-Feng Lin; Shuying Wang; Yu-Hung Chen; Trai-Ming Yeh; Hsiao-Sheng Liu; Robert Anderson; Yee-Shin Lin
Journal:  J Biomed Sci       Date:  2013-06-13       Impact factor: 8.410

10.  Dengue Virus Directly Stimulates Polyclonal B Cell Activation.

Authors:  Arturo Ramon Vargas Correa; Ana Carolina Egypto Rosa Berbel; Michelle Premazzi Papa; Ana Theresa Silveira de Morais; Ligia Maria Torres Peçanha; Luciana Barros de Arruda
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.